Mr. David Cry is the founder and Chief Executive Officer of The Adrenoleukodystrophy (ALD) Foundation. He first began having symptoms of Adrenomyeloneuropathy in the fall of 1997. Since that time, David has overcome tremendous obstacles in order to assist with the development of novel therapies that will combat the effects of both ALD and AMN.
David's approach toward building coalitions with committed medical professionals interested in finding solutions in the ALD community, lead to the formation of The Adrenoleukodystrophy Foundation. The aim of The ALD Foundation is to assist families, raise global awareness, educate physicians, and ultimately, the eradication of ALD.